Editorial: Bacteriocins and Other Ribosomally Synthesised and Post-translationally Modified Peptides (RiPPs) as Alternatives to Antibiotics
dc.contributor.author | Mathur, H | |
dc.contributor.author | Field, D | |
dc.contributor.author | Upton, Mathew | |
dc.contributor.author | Cotter, PD | |
dc.date.accessioned | 2021-07-26T16:20:54Z | |
dc.date.issued | 2021-06-08 | |
dc.identifier.issn | 1664-302X | |
dc.identifier.issn | 1664-302X | |
dc.identifier.other | ARTN 695081 | |
dc.identifier.uri | http://hdl.handle.net/10026.1/17376 | |
dc.description.abstract |
This Research Topic concerns bacteriocins and others RiPPs (Ribosomally synthesized and Post-translationally modified Peptides) as alternatives to antibiotics. Due to the increasing problem of antibiotic resistance globally, there is a pressing need to source such alternative antimicrobials. Here, in this editorial, we summarize the key papers that were published as part of this Research Topic, which consisted of a diverse range of research as well as review articles, pertaining to several different bacteriocins and RiPPs. | |
dc.format.extent | 695081- | |
dc.format.medium | Electronic-eCollection | |
dc.language | eng | |
dc.language.iso | en | |
dc.publisher | Frontiers Media | |
dc.subject | bacteriocins | |
dc.subject | RiPPs | |
dc.subject | antimicrobials | |
dc.subject | antimicrobial resistance | |
dc.subject | genetic engineering | |
dc.title | Editorial: Bacteriocins and Other Ribosomally Synthesised and Post-translationally Modified Peptides (RiPPs) as Alternatives to Antibiotics | |
dc.type | journal-article | |
dc.type | Editorial | |
plymouth.author-url | https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000664519700001&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=11bb513d99f797142bcfeffcc58ea008 | |
plymouth.volume | 12 | |
plymouth.publication-status | Published online | |
plymouth.journal | Frontiers in Microbiology | |
dc.identifier.doi | 10.3389/fmicb.2021.695081 | |
plymouth.organisational-group | /Plymouth | |
plymouth.organisational-group | /Plymouth/Faculty of Health | |
plymouth.organisational-group | /Plymouth/Faculty of Health/School of Biomedical Sciences | |
plymouth.organisational-group | /Plymouth/REF 2021 Researchers by UoA | |
plymouth.organisational-group | /Plymouth/REF 2021 Researchers by UoA/UoA01 Clinical Medicine | |
plymouth.organisational-group | /Plymouth/Research Groups | |
plymouth.organisational-group | /Plymouth/Research Groups/Institute of Translational and Stratified Medicine (ITSMED) | |
plymouth.organisational-group | /Plymouth/Research Groups/Institute of Translational and Stratified Medicine (ITSMED)/CBR | |
plymouth.organisational-group | /Plymouth/Research Groups/Plymouth Institute of Health and Care Research (PIHR) | |
plymouth.organisational-group | /Plymouth/Users by role | |
plymouth.organisational-group | /Plymouth/Users by role/Academics | |
plymouth.organisational-group | /Plymouth/Users by role/Researchers in ResearchFish submission | |
dc.publisher.place | Switzerland | |
dcterms.dateAccepted | 2021-05-10 | |
dc.rights.embargodate | 2021-7-28 | |
dc.identifier.eissn | 1664-302X | |
dc.rights.embargoperiod | Not known | |
rioxxterms.versionofrecord | 10.3389/fmicb.2021.695081 | |
rioxxterms.licenseref.uri | http://www.rioxx.net/licenses/all-rights-reserved | |
rioxxterms.licenseref.startdate | 2021-06-08 | |
rioxxterms.type | Journal Article/Review |